Imprimer

1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one ≥98% (par CCM)

Marques : ENZO LIFE SCIENCES
Ratings: Ecrire un avis

Total Evaluation: 0
Moyenne des Notes : 0.0 sur 5

ALX270034M010 ALX270034M050
ENZOALX270034M010EA 107 EUR
ENZOALX270034M010 ENZOALX270034M050
1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one ≥98% (par CCM)
1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one

Guanylyl cyclase inhibitor


ODQ is a potent and selective, direct-acting inhibitor of guanylate cyclase (IC50=20 nM). In cerebellar slices ODQ reversibly inhibited cGMP generation in response to endogenous NO or exogenously added NO-donors. ODQ does not inhibit NO-mediated macrophage toxicity (a phenomenon unrelated to cGMP) and does not inhibit particulate guanylyl cyclase or adenylyl cyclase. ODQ is an unique and selective tool to elucidate the physiological importance of the NO-cGMP pathway.

Formule: C₉H₅N₃O₂
Numéro MDL: MFCD00792620
Numéro CAS: 41443-28-1

Commander maintenant


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Plus About VWR